Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on December 16th, 2015 by Joyce de LangenPharmacovigilance
Limitations of clinical trials and traditional post-marketing sources of safety information.
Due to limitations of pre-marketing clinical trials, there isn’t much information available once a medicinal product is authorized for marketing. (more…)
Posted on December 16th, 2015 by James DunstanPharmacovigilance
At the beginning of September 2015, the EMA launched the Medical Literature Monitoring (MLM) service. I recently read the EMA’s MLM launch phase closure report in addition to information from a recent EMA information day and have highlighted some key points below. (more…)
Posted on December 14th, 2015 by David EvansChemistry
After years of hard work, late nights and hours of toil in the lab, the sought after chemistry PhD can aid young scientists towards a successful career. In such a competitive setting, it’s vital to make sure you stand out as a researcher from the start. (more…)
Posted on December 4th, 2015 by Agnieszka FredaChemistry
As a chemist you work with chemical compounds every day studying, mixing, separating, modifying. You know that we are made up of chemicals, and that if we zoom in close enough we will be visible as clusters of proteins, lipids, sugars, some metals and nonmetals. (more…)
Posted on December 1st, 2015 by Thibault GeouiPharma R&D
What is a Taxonomy?
A taxonomy is a system to classify objects or concepts. We all use such systems to bring order into different aspects of our lives, be it food in the refrigerator, clothes in the closet or files on our laptops. (more…)
Posted on November 24th, 2015 by Joyce de LangenPharmacovigilance
On 16 April 2014, the new EU Clinical Trial Regulation on medicines for human use was adopted. The purpose of the new Clinical Trial Regulation is to create an environment that is favourable for conducting clinical trials, with the highest standards for patient safety, within the EU. (more…)
About this Blog
The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.
Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier, its affiliates and sponsors or its parent company, Reed Elsevier.